Guest guest Posted November 18, 2007 Report Share Posted November 18, 2007 Shoveling manure, that's what! And that is what the cancer industry often does when they announce new drugs and breakthroughs. As Doctor Moss has pointed out in the past, most often those breakthroughs amount to mere weeks or a few months of survival - weeks, or pehaps months, during which the patient is suffering horribly from the side effects of chemo and/or radiation. Such appears to be the case with Tykerb - as the article you posted clearly shows, at most they can point to two extra months in a very limited study group. My opinion - yet another rip off that will reap profits that reach into the billions while achieving at best a temporary increase in tumor shrinkage and a few weeks of additional suffering. If the profits from just one mainstream featured drug were put into genuine research of the best natural ways to prevent and cure cancer through diet, nutrition, lifestyle, cleansing and the healing plants found in nature, it would save millions of lives every year. But since that would come at the price of hundreds of billions of dollars each year in profits to the cancer industry we will not likely see it from them or the organizations some of those billions are used to control. Humanity versus profits has not been a fair contest dating back to at least the late 1800's when those who control the world pharmaceutical empire and mainstream medicine began their takeover and elimination of natural and homeopathic healing. Fortunately, there are a growing number of people like you, my very dear friends Dr. G, , David, Marc and so many more here in this group, who also know that there has never been, and likely never will be, any contest when it comes to natural healing and wellness versus mainstream managed illness - and we are doing our best to spread the word as far as we can and help as many as we can. Live long, live healthy, live happy! The Best Years in Life www.tbyil.com oleander soup , robert-blau wrote: > > And wait 'til you read the " side effects " . . . > > (Cancer Decisions News Staff) > > Ralph W. Moss, Ph.D. Weekly CancerDecisions.com > Newsletter #315 11/18/07 > > THE MOSS REPORTS - CANCER DECISIONS NEWSLETTER > > Earlier this year, the US Food and Drug Administration (FDA) approved > the drug Tykerb (lapatinib) to treat advanced breast cancer. What can > breast cancer patients realistically expect from this drug? > > To read or listen to this week's newsletter, please click here or go to: > > http://www.cancerdecisions.com/111807.html > > [and scroll down to bottom of page] > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.